About
AboutNovo GroupLeadershipResponsibilityNovo Nordisk Foundation
Investments
InvestmentsAreas
Life Science
Seed InvestmentsVenture InvestmentsGrowth InvestmentsPrincipal InvestmentsBioindustrial Investments
Capital Investments
StrategyRegions
North AmericaEuropeAsia
Portfolio
People & Careers
PeopleCareers
Open positions
News & Reports
News & ReportsFacts & figuresPress FAQMedia library
Scott A. Beardsley

Departments

Life Sciences Operating Committee, Novo Ventures (US), Inc., Venture Investments

Position

Managing Partner

Scott joined Venture Investments (US) Inc. in San Francisco, California in 2012. Previously, he was a board member of Aerocrine AB.

From 2009-2012, Scott was part of Novo A/S’ Growth Equity team. Prior to joining Novo A/S he was a Managing Director at JP Morgan in San Francisco, heading the firm’s West Coast biopharmaceuticals effort. Previous to that, Scott led Piper Jaffray’s US biopharmaceuticals investment banking practice and was a member of the Health Care Group at Montgomery Securities. During his tenure as an investment banker, Scott originated and executed numerous transactions.

Scott holds an MBA from UCLA’s Anderson Graduate School of Management and a BS from Colorado State University.

Investing to benefit people and the planet

Novo Holdings A/S

Tuborg Havnevej 19

2900 Hellerup Denmark

+45 3527 6500 CVR# 24257630

Media Relations

Christian Mostrup Scheel

Head of Public Relations

cims@novo.dk +45 3067 4805

Novo Holdings Equity US Inc.*

One Market Plaza, Floor 17 of the Steuart Tower

San Francisco, CA 94105 USA

+1 (415) 363-0858

Novo Holdings Equity Asia Pte. Ltd.*

#40-01, 6 Battery Road

Singapore 049909

Novo Holdings Equity US Inc.*

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

Novo Holdings (UK office)

16 Berkeley Street

London W1J 8DZ

Novo Ventures (US) Inc.*

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

Privacy noticeWhistleblowerArticles of association Policy on data ethicsElectronic invoicingDiversity policy

*Novo Ventures (US) Inc., Novo Holdings Equity US Inc., comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Ltd. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.

Follow us